| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; fig 3c
| Varešlija D, McBryan J, Fagan A, Redmond A, Hao Y, Sims A, et al. Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors. Clin Cancer Res. 2016;22:2765-77 pubmed publisher |
- immunohistochemistry; human; 1:50
| Adachi K, Miki Y, Saito R, Hata S, Yamauchi M, Mikami Y, et al. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis. Hum Pathol. 2015;46:1685-93 pubmed publisher |
- immunohistochemistry - paraffin section; rat
| Ammar A, Esmat A, Hassona M, Tadros M, Abdel-Naim A, Guns E. The effect of pomegranate fruit extract on testosterone-induced BPH in rats. Prostate. 2015;75:679-92 pubmed publisher |
- immunohistochemistry; human; 1:200
| Ferguson D, Long D, Smith M, Craig-Owens L, Means J, Fadare O, et al. Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas. J Ovarian Res. 2015;8:34 pubmed publisher |
- immunohistochemistry - paraffin section; human
| Li L, Wang Q, Lv X, Sha L, Qin H, Wang L, et al. Expression and localization of estrogen receptor in human breast cancer and its clinical significance. Cell Biochem Biophys. 2015;71:63-8 pubmed publisher |
- immunohistochemistry; human; 1:400
| Winczura P, Sosinska-Mielcarek K, Duchnowska R, Badzio A, Lakomy J, Majewska H, et al. Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients. Pathol Oncol Res. 2015;21:1229-36 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:35
| Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40 pubmed publisher |
- immunohistochemistry; human; 1:200
| Faupel-Badger J, Duggan M, Sherman M, Garcia-Closas M, Yang X, Lissowska J, et al. Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer. 2014;5:42-50 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:200
| Gao L, Yue M, Davis J, Hyjek E, Schuger L. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor. Virchows Arch. 2014;464:495-503 pubmed publisher |
- immunohistochemistry; human
| Booth M, Hanby A, Speirs V. Steroid hormone receptor expression in breast cancer stroma. Breast Cancer Res Treat. 2014;143:605-7 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:300
| Im S, Choi H, Yoo C, Jung J, Jeon Y, Suh Y, et al. Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival. Korean J Pathol. 2013;47:116-23 pubmed publisher |
- immunohistochemistry - paraffin section; human
| Doberstein K, Milde-Langosch K, Bretz N, Schirmer U, Harari A, Witzel I, et al. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor. BMC Cancer. 2014;14:958 pubmed publisher |
| Mohammed H, Russell I, Stark R, Rueda O, Hickey T, Tarulli G, et al. Progesterone receptor modulates ERα action in breast cancer. Nature. 2015;523:313-7 pubmed publisher |
| Clark S, Warwick J, Carpenter R, Bowen R, Duffy S, Jones J. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer. 2011;104:120-7 pubmed publisher |
